Early evidence for the safety of certain COVID-19 vaccines using empirical Bayesian modeling from VAERS
von Csefalvay, C.
Show abstract
The advent of vaccines against SARS-CoV-2 ushered in an unprecedented global response to COVID-19, with the largest and most ambitious mass vaccination campaign in human history. The scale of this effort means that safety signals suggesting adverse effects may only be detectable using passive reporting. This paper examines reports to the CDC/FDAs VAERS system in the first six months of 2021, using an empirical Bayesian model with a gamma Poisson shrinker to identify potential safety signals from COVID-19 vaccines currently on the U.S. market. Based on this preliminary data, it is concluded that the COVID-19 vaccines safety significantly exceeds that of previously marketed vaccines, and other than a known risk of thrombotic events, no safety signals of concern emerge.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine reported to EudraVigilance database 94%
- Analysis of immunization, adverse events, and efficacy of a fourth dose of BNT162b2 vaccine 94%
- Safety and immunogenicity of the BBIBP-CorV vaccine in adolescents aged 12-17 years in Thai population, prospective cohort study 93%
Similar papers in this journal
- Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework 94%
- A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and Myocarditis using Five European Databases 94%
- A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: safety, reactogenicity and immunogenicity 94%
Similar papers in this journal
- Immunogenicity and safety of Quadrivalent Influenza HA vaccine compared with Trivalent Influenza HA vaccine and evaluation of Quadrivalent Influenza HA vaccine batch-to-batch consistency in Indonesian children and adults 93%
- Covid-19 Vaccination in Pregnancy: A Systematic Review 93%
- Imbalanced Machine Learning Classification Models For Removal Biosimilar Drugs And Increased Activity In Patients With Rheumatic Diseases 92%
Similar papers in this journal
- Adverse events following COVID-19 vaccination in young Japanese people: A case-control study of the risk of systemic adverse events by a questionnaire surveyShort title: COVID-19 vaccine adverse events in young Japanese 93%
- Adverse events following COVID-19 virus vaccination in Japanese young population: The first cross-sectional study conducted by a questionnaire survey after the first-time-injection 92%
- The SARS-CoV-2 cellular receptor ACE2 is expressed in oropharyngeal cells and is modulated in vitro by the bacterial lysate Lantigen B 88%
Similar papers in this journal
- COVID-19 vaccines and evidence-based medicine 93%
- Reports of myocarditis and pericarditis following mRNA COVID-19 vaccines: A systematic review of spontaneously reported data from the UK, Europe, and the US and of the literature 92%
- Vaccination or restriction?: COVID-19 vaccine hesitancy and vaccine passports 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.